The differences between GluN2A and GluN2B signaling in the brain. Issue 8 (22nd April 2018)

• Record Type: Journal Article
• Authors: Sun, Yongjun; Xu, Yingge; Cheng, Xiaokun; Chen, Xi; Xie, Yinghua; Zhang, Linan; Wang, Long; Hu, Jie; Gao, Zibin
• Is Part Of: Journal of neuroscience research. Volume 96:Issue 8(2018)
• Page Start: 1430
• Page End: 1443
• Publication Date: 2018-04-22
• Subjects: GluN2A -- GluN2B -- N‐methyl‐d‐aspartate receptor -- signaling differences; Neurobiology -- Periodicals; 612
• DOI: 10.1002/jnr.24251
• Languages: English
• ISSNs: 0360-4012

Abstract

Abstract: The N ‐methyl‐d ‐aspartate (NMDA) receptor, a typical ionotropic glutamate receptor, is a crucial protein for maintaining brain function. GluN2A and GluN2B are the main types of NMDA receptor subunit in the adult forebrain. Studies have demonstrated that they play different roles in a number of pathophysiological processes. Although the underlying mechanism for this has not been clarified, the most fundamental reason may be the differences between the signaling pathways associated with GluN2A and GluN2B. With the aim of elucidating the reasons behind the diverse roles of these two subunits, we described the signaling differences between GluN2A and GluN2B from the aspects of C‐terminus‐associated molecules, effects on typical downstream signaling proteins, and metabotropic signaling. Because there are several factors interfering with the determination of subunit‐specific signaling, there is still a long way to go toward clarifying the signaling differences between these two subunits. Developing better pharmacology tools, such as highly selective antagonists for triheteromeric GluN2A‐ and GluN2B‐containing NMDA receptors, and establishing new molecular biological methods, for example, engineering photoswitchable NMDA receptors, may be useful for clarifying the signaling differences between GluN2A and GluN2B.